2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of thePneumococcal Vaccine Market?

The surge in cases of pneumococcal contamination is projected to boost the growth of the pneumococcal vaccine market. Pneumococcal contamination signifies any infection instigated by the bacteria Streptococcus pneumoniae, or pneumococcus. These infections can be manifested as pneumonia, bloodstream infections, ear infections, or sinus infections. The pneumococcal vaccine plays a significant role by urging the body to generate antibodies to counter pneumococcal bacteria, thereby minimizing or eliminating bacteria and toxins responsible for infections. This course of action thereby protects children, elderly people, and those with compromised immune systems against various types of pneumococcal infections. As per a report by the Center for Disease Control and Prevention in January 2022, Pneumococcal pneumonia results in an estimated 150,000 hospitalizations every year within the United States, representing up to 30% of community-acquired pneumonia in adults. Therefore, the rise in instances of pneumococcal contamination is contributing to the development of the pneumococcal vaccine market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11950&type=smp

How Has the Pneumococcal Vaccine Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

In recent times, the pneumococcal vaccine market has seen substantial growth. The market, which stood at $8.94 billion in 2024, is projected to increase to $9.49 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.2%. The notable expansion during the historic period can be associated with factors such as the discovery of streptococcus pneumoniae, public health concern, initiatives towards early vaccination, advancements in healthcare, and alterations in vaccine policies.

In the coming years, the pneumococcal vaccine market is predicted to experience robust growth. The market is projected to expand to a size of $12.12 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth during the projected period include the emergence of new pneumococcal strains, ongoing research and development, prioritizing immunization, increasing vaccine access, and aging population. Prominent trends anticipated during this term include the development of multivalent vaccines, vaccination of high-risk groups, enhancing vaccine effectiveness, promoting caution and knowledge through campaigns, and focusing on infant immunization.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11950

What Are the Latest Innovations Influencing thePneumococcal Vaccine Market?

In an effort to boost their profitability, key players in the pneumococcal vaccine market are pioneering new products. Notably, Merck & Co Inc., an American pharmaceutical entity, introduced the V116 vaccine in July 2023. Conceived to tackle the eight unique serotypes of Streptococcus pneumoniae primarily causing adult pneumococcal diseases, V116 outperforms other pneumococcal vaccines in terms of immunogenicity towards various serotypes in adult demographics. Additionally, it has generated favorable immune reactions in both individuals receiving vaccination for the first time and those previously vaccinated. Currently undergoing Phase 3 development, V116 has been accorded breakthrough therapy status by the U.S Food and Drug Administration (FDA).

Who Are the Major Industry Players Accelerating Growth in thePneumococcal Vaccine Market?

Major companies operating in the pneumococcal vaccine market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Astellas Pharma Inc., CSL Limited, Anhui Zhifei Longcom Biopharmaceutical Co. Ltd, Serum Institute of India Private Limited, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd, Biological E Limited, Hualan Biological Engineering Inc., Beijing Minhai Biotechnology Limited Company, NPO Petrovax Pharm LLC, Vaxcyte Inc., Panacea Biotec Ltd, Inventprise LLC, Tergene Biotech Private Limited, PnuVax Incorporated, SK Bioscience Co Ltd

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report

Which Primary Segments of the Pneumococcal Vaccine Market Are Driving Growth and Industry Transformations?

The pneumococcal vaccine market covered in this report is segmented –

1) By Product Type: Prevnar 13, Synflorix, Pneumovax23, Other Products

2) By Route of Administration: Intravenous, Intramuscular, Subcutaneous

3) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels

4) By End User: Pediatrics, Adults

Subsegments:

1) By Prevnar 13: Pediatric Formulation, Adult Formulation

2) By Synflorix: Pediatric Formulation, Adult Formulation

3) By Pneumovax23: Single-Dose Vials, Pre-Filled Syringes

4) By Other Products: PCV15 (Vaxneuvance), PCV20 (Prevnar 20), Other Regional Pneumococcal Vaccines

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11950&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of thePneumococcal Vaccine Market?# Market?

North America was the largest region in the pneumococcal vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumococcal vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Pneumococcal Vaccine Maret 2025, By The Business Research Company:

Medical Waste Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-waste-management-global-market-report

Medical Device Cleaning Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-device-cleaning-global-market-report

Medical Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: